Menu Search
Equities

Zhejiang Huakang Pharmaceutical Co Ltd

605077:SHH

Zhejiang Huakang Pharmaceutical Co Ltd

Actions
Consumer Staples Food Producers
  • Price (CNY)15.61
  • Today's Change-0.18 / -1.14%
  • Shares traded5.67m
  • 1 Year change-9.61%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Zhejiang Huakang Pharmaceutical Co Ltd grew revenues 26.48% from 2.20bn to 2.78bn while net income improved 16.34% from 319.28m to 371.45m.
Gross margin20.88%
Net profit margin10.00%
Operating margin10.88%
Return on assets5.23%
Return on equity9.56%
Return on investment6.46%
More ▼

Cash flow in CNYView more

In 2023, Zhejiang Huakang Pharmaceutical Co Ltd increased its cash reserves by 107.82%, or 1.10bn. Cash Flow from Financing totalled 1.74bn or 62.60% of revenues. In addition the company generated 619.47m in cash from operations while cash used for investing totalled 1.26bn.
Cash flow per share--
Price/Cash flow per share--
Book value per share10.26
Tangible book value per share8.12
More ▼

Balance sheet in CNYView more

Zhejiang Huakang Pharmaceutical Co Ltd has a Debt to Total Capital ratio of 41.01%, a higher figure than the previous year's 31.87%.
Current ratio1.93
Quick ratio1.56
Total debt/total equity0.698
Total debt/total capital0.4101
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 16.67% and 16.14%, respectively. The positive trend in dividend payments is noteworthy since only some companies in the Food Processing industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)57.90%
EPS growth(5 years)6.10
EPS (TTM) vs
TTM 1 year ago		-18.05
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.